Stanton Marshall S.
SEC CIK 1849615 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AORT | ARTIVION, INC. | SVP, Clinical, MD Affair | 60.1K | — | $6.17M | 39 | 2022-02-17 | 2026-03-03 |
Most active insiders at AORT, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mackin James P | Pres, CEO | — | $9.72M |
| 2 | Stanton Marshall S. | SVP, Clinical, MD Affair | — | $3.43M |
| 3 | Holloway Jean F | SVP, GC | — | $2.54M |
| 4 | Davis John E | Chief Commercial Off | — | $1.75M |
| 5 | GREEN ANDREW M | SVP, Regulatory, Quality | — | $1.43M |
| 6 | Horton Amy | VP, CAO | — | $870.1K |
| 7 | Berry Lance A | EVP, COO, CFO, Treas | — | $803.2K |
| 8 | Hoff Elizabeth A | Dir | — | $189.4K |
| 9 | SEMEDO ANTHONY B. | Dir | — | — |
| 10 | Borgstrom Marna P | Dir | — | — |
Transactions 39
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-04 | 2026-03-02 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +21.8K | 62.2K | +54% | $0 | |
| 2026-03-04 | 2026-03-03 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $37.78 | -2,149 | 60.1K | -3% | -$81.2K | |
| 2026-03-03 | 2026-03-02 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $38.02 | -1,513 | 40.4K | -4% | -$57.5K | |
| M | 2026-02-25 | 2026-02-23+ | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $36.94 | -3,682 | 41.9K | -8% | -$136.0K |
| DM | 2025-11-24 | 2025-11-21 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale+OE | $45.04 | -47.4K | 44.8K | -51% | -$2.13M |
| DM | 2025-11-24 | 2025-11-21 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | M - OptEx | $14.21 | +47.4K | 71.8K | +194% | +$673.0K |
| DM | 2025-11-24 | 2025-11-20 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | M - OptEx | $15.48 | +3,388 | 46.8K | +8% | +$52.4K |
| DM | 2025-11-24 | 2025-11-20 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale+OE | $44.18 | -15.3K | 44.8K | -25% | -$674.8K |
| 2025-11-14 | 2025-11-13 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $45.86 | -4,993 | 56.6K | -8% | -$229.0K | |
| 2025-11-12 | 2025-11-10 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $44.62 | -2,566 | 61.6K | -4% | -$114.5K | |
| D | 2025-08-28 | 2025-08-27 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | M - OptEx | $11.03 | +18.2K | 82.4K | +28% | +$200.7K |
| D | 2025-08-28 | 2025-08-27 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale+OE | $44.02 | -18.2K | 64.2K | -22% | -$801.2K |
| M | 2025-06-18 | 2025-06-17 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $29.50 | -15.0K | 64.2K | -19% | -$442.5K |
| M | 2025-06-16 | 2025-06-13 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $28.44 | -26.1K | 79.2K | -25% | -$743.1K |
| M | 2025-05-12 | 2025-05-09 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $29.13 | -10.5K | 110.1K | -9% | -$307.3K |
| 2025-03-10 | 2025-03-06 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +19.2K | 117.5K | +20% | $0 | |
| 2025-03-10 | 2025-03-06 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $24.80 | -1,603 | 115.9K | -1% | -$39.8K | |
| 2025-03-04 | 2025-02-28 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +18.4K | 98.2K | +23% | $0 | |
| M | 2025-02-26 | 2025-02-24 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $27.31 | -4,687 | 79.8K | -6% | -$128.0K |
| 2024-03-21 | 2024-03-20 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.39 | -2,183 | 83.3K | -3% | -$44.5K | |
| MA | 2024-03-14 | 2024-02-23 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +16.0K | 83.2K | +24% | $0 |
| MA | 2024-03-14 | 2024-02-26 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,007 | 72.5K | -4% | -$61.0K |
| A | 2024-03-14 | 2024-02-27 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81.3K | -0.6% | -$9,221 |
| A | 2024-03-14 | 2024-03-01 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $18.72 | -1,506 | 85.5K | -2% | -$28.2K |
| A | 2024-03-14 | 2024-03-01 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +5,724 | 87.0K | +7% | $0 |
| 2024-03-07 | 2024-03-05 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $18.72 | -1,506 | 85.4K | -2% | -$28.2K | |
| 2024-03-07 | 2024-03-01 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +5,724 | 86.9K | +7% | $0 | |
| 2024-02-29 | 2024-02-27 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $19.83 | -465 | 81.2K | -0.6% | -$9,221 | |
| M | 2024-02-28 | 2024-02-26 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $20.27 | -3,048 | 72.5K | -4% | -$61.8K |
| M | 2024-02-28 | 2024-02-23 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +16.0K | 74.1K | +28% | $0 |
| 2024-02-26 | 2024-02-23 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +14.8K | 68.7K | +27% | $0 | |
| 2023-03-03 | 2023-03-02 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $13.41 | -907 | 52.1K | -2% | -$12.2K | |
| 2023-03-03 | 2023-03-01 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +3,663 | 53.0K | +7% | $0 | |
| M | 2023-03-01 | 2023-02-23 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +11.2K | 50.5K | +29% | $0 |
| M | 2023-03-01 | 2023-02-27 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | S - Sale | $12.94 | -2,337 | 49.3K | -5% | -$30.2K |
| D | 2022-11-10 | 2022-11-08 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +19.4K | 39.2K | +98% | $0 |
| D | 2022-02-24 | 2022-02-23 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +8,406 | 19.7K | +74% | $0 |
| 2022-02-22 | 2022-02-17 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | F - Tax | $17.50 | -772 | 11.3K | -6% | -$13.5K | |
| 2022-02-22 | 2022-02-17 | AORT | ARTIVION, INC. | Stanton Marshall S. | SVP, Clinical, MD Affair | A - Grant | $0.00 | +2,603 | 12.1K | +27% | $0 |
Purchase Sale Sale after option exercise All abbreviations